{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:23:22Z","timestamp":1779110602867,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10787-025-01791-1","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T10:46:05Z","timestamp":1749552365000},"page":"3403-3410","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Naproxen and prednisolone reduced intestinal alteration and permeability and bacterial translocation in rat adjuvant-induced arthritis"],"prefix":"10.1007","volume":"33","author":[{"given":"Sophie","family":"Hecquet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perle","family":"Totoson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Saas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul","family":"Pais-de-Barros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maude","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9ment","family":"Prati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Wendling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Demougeot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2708-2918","authenticated-orcid":false,"given":"Frank","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"issue":"2","key":"1791_CR1","doi-asserted-by":"publisher","first-page":"G590","DOI":"10.1152\/ajpgi.00252.2006","volume":"292","author":"MA Boivin","year":"2007","unstructured":"Boivin MA, Ye D, Kennedy JC, Al-Sadi R, Shepela C, Ma TY (2007) Mechanism of glucocorticoid regulation of the intestinal tight junction barrier. Am J Physiol Gastrointest Liver Physiol 292(2):G590\u2013G598","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"1791_CR2","first-page":"464","volume":"22","author":"NA Bokulich","year":"2016","unstructured":"Bokulich NA, Battaglia T, Aleman JO, Walker JM, Blaser MJ, Holt PR (2016) Celecoxib does not alter intestinal microbiome in a longitudinal diet-controlled study. Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis 22(5):464\u2013465","journal-title":"Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"1791_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2023.154438","volume":"79","author":"C Chaignat","year":"2024","unstructured":"Chaignat C, Lagrost L, Moretto K, de Barros JPP, Winiszewski H, Grober J et al (2024) Plasma citrulline concentration and plasma LPS detection among critically ill patients a prospective observational study. J Crit Care F\u00e9vr 79:154438","journal-title":"J Crit Care F\u00e9vr"},{"issue":"1","key":"1791_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/BOR.0000000000000239","volume":"28","author":"F Ciccia","year":"2016","unstructured":"Ciccia F, Rizzo A, Triolo G (2016a) Subclinical gut inflammation in ankylosing spondylitis. Curr Opin Rheumatol Janv 28(1):89\u201396","journal-title":"Curr Opin Rheumatol Janv"},{"issue":"5","key":"1791_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.berh.2016.10.003","volume":"30","author":"F Ciccia","year":"2016","unstructured":"Ciccia F, Ferrante A, Guggino G, Triolo G (2016b) The role of the gastrointestinal tract in the pathogenesis of rheumatic diseases. Best Pract Res Clin Rheumatol 30(5):889\u2013900","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"1791_CR6","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/annrheumdis-2016-210000","volume":"76","author":"F Ciccia","year":"2017","unstructured":"Ciccia F, Guggino G, Rizzo A, Alessandro R, Luchetti MM, Milling S et al (2017) Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis. Ann Rheum Dis 76(6):1123\u20131132","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1791_CR7","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3390\/cells12050728","volume":"12","author":"M d\u2019Angelo","year":"2023","unstructured":"d\u2019Angelo M, Brandolini L, Catanesi M, Castelli V, Giorgio C, Alfonsetti M et al (2023) Differential effects of nonsteroidal anti-inflammatory drugs in an in vitro model of human leaky gut. Cells 12(5):728","journal-title":"Cells"},{"issue":"5","key":"1791_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10787-014-0200-5","volume":"22","author":"RM El-Sayed","year":"2014","unstructured":"El-Sayed RM, Moustafa YM, El-Azab MF (2014) Evening primrose oil and celecoxib inhibited pathological angiogenesis, inflammation, and oxidative stress in adjuvant-induced arthritis: novel role of angiopoietin-1. Inflammopharmacology 22(5):305\u2013317","journal-title":"Inflammopharmacology"},{"issue":"3","key":"1791_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.7326\/0003-4819-126-3-199702010-00003","volume":"126","author":"HI Feldman","year":"1997","unstructured":"Feldman HI, Kinman JL, Berlin JA, Hennessy S, Kimmel SE, Farrar J et al (1997) Parenteral ketorolac: the risk for acute renal failure. Ann Intern Med 126(3):193\u2013199","journal-title":"Ann Intern Med"},{"issue":"4","key":"1791_CR10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.semarthrit.2021.04.015","volume":"51","author":"S Hecquet","year":"2021","unstructured":"Hecquet S, Totoson P, Martin H, Prati C, Wendling D, Demougeot C et al (2021) Intestinal permeability in spondyloarthritis and rheumatoid arthritis: a systematic review of the literature. Semin Arthritis Rheum 51(4):712\u2013718","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"1791_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13075-023-03069-9","volume":"25","author":"S Hecquet","year":"2023","unstructured":"Hecquet S, Totoson P, Martin H, Algros MP, Saas P, Pais-de-Barros JP et al (2023) Increased gut permeability and intestinal inflammation precede arthritis onset in the adjuvant-induced model of arthritis. Arthritis Res Ther 25(1):95","journal-title":"Arthritis Res Ther"},{"key":"1791_CR12","volume":"2014","author":"AD Kshirsagar","year":"2014","unstructured":"Kshirsagar AD, Panchal PV, Harle UN, Nanda RK, Shaikh HM (2014) Anti-inflammatory and antiarthritic activity of anthraquinone derivatives in rodents. Int J Inflamm 2014:690596","journal-title":"Int J Inflamm"},{"issue":"3","key":"1791_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/cells8030251","volume":"8","author":"B L\u00e1z\u00e1r","year":"2019","unstructured":"L\u00e1z\u00e1r B, Brenner GB, Makkos A, Balogh M, L\u00e1szl\u00f3 SB, Al-Khrasani M et al (2019) Lack of small intestinal dysbiosis following long-term selective inhibition of cyclooxygenase-2 by rofecoxib in the rat. Cells 8(3):251","journal-title":"Cells"},{"key":"1791_CR14","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3389\/fphar.2020.01153","volume":"11","author":"D Maseda","year":"2020","unstructured":"Maseda D, Ricciotti E (2020) NSAID-Gut microbiota interactions. Front Pharmacol 11:1153","journal-title":"Front Pharmacol"},{"issue":"6","key":"1791_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101493","volume":"33","author":"D Mauro","year":"2020","unstructured":"Mauro D, Ciccia F (2020) Gut dysbiosis in Spondyloarthritis: cCause or effect? Best Pract Res Clin Rheumatol 33(6):101493","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"9","key":"1791_CR16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1158\/1940-6207.CAPR-16-0095","volume":"9","author":"DC Montrose","year":"2016","unstructured":"Montrose DC, Zhou XK, McNally EM, Sue E, Yantiss RK, Gross SS et al (2016) Celecoxib alters the intestinal microbiota and metabolome in association with reducing polyp burden. Cancer Prev Res Phila Pa Sept 9(9):721\u2013731","journal-title":"Cancer Prev Res Phila Pa Sept"},{"issue":"6965","key":"1791_CR17","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nature02119","volume":"426","author":"N Sakaguchi","year":"2003","unstructured":"Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S et al (2003) Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426(6965):454","journal-title":"Nature"},{"issue":"1","key":"1791_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","volume":"14","author":"J Torres","year":"2020","unstructured":"Torres J, Bonovas S, Doherty G, Kucharzik T, Gisbert JP, Raine T et al (2020) ECCO guidelines on therapeutics in Crohn\u2019s disease: medical treatment. J Crohns Colitis 14(1):4\u201322","journal-title":"J Crohns Colitis"},{"issue":"3","key":"1791_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1046\/j.1365-2036.2003.01611.x","volume":"18","author":"GE Wild","year":"2003","unstructured":"Wild GE, Waschke KA, Bitton A, Thomson ABR (2003) The mechanisms of prednisone inhibition of inflammation in Crohn\u2019s disease involve changes in intestinal permeability, mucosal TNFalpha production and nuclear factor kappa B expression. Aliment Pharmacol Ther 18(3):309\u2013317","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"1791_CR20","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00109-021-02045-7","volume":"99","author":"P Xu","year":"2021","unstructured":"Xu P, Elizalde M, Masclee A, Pierik M, Jonkers D (2021) Corticosteroid enhances epithelial barrier function in intestinal organoids derived from patients with Crohn\u2019s disease. J Mol Med Berl Ger Juin 99(6):805\u2013815","journal-title":"J Mol Med Berl Ger Juin"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01791-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01791-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01791-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:18:44Z","timestamp":1751354324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01791-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1791"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01791-1","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest in relation to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Aall experiments and protocols were approved by the French Department of regulated research practice (APAFIS number #8699-2017010210088460) and the Ethics Committee in animal experimentation of Besancon (agreement number CE058, user establishment approval number C2505610). They complied with ARRIVE guidelines and conformed to the European convention for the protection of vertebrate animals used for experimental and other scientific purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}